Nuytemans, K, Franzen, S, Broce, IJ, Caramelli, P, Ellajosyula, R, Finger, E, Gupta, V, Gupta, V, Illan-Gala, I, Loi, SM, Morhardt, D, Pijnenburg, Y, Rascovsky, K, Williams, MM, Yokoyama, JS, Acosta-Uribe, J, Akinyemi, R, Alladi, S, Ayele, BA, Ayhan, Y, Bourdage, R, Castro-Suarez, S, de Souza, LC, Dacks, P, de Boer, SCM, de Leon, J, Dodge, S, Grasso, S, Ghoshal, N, Kamath, V, Kumfor, F, Matias-Guiu, JA, Narme, P, Nielsen, TR, Okhuevbie, D, Pina-Escudero, S, Ruiz-Garcia, R, Ryan, B, Scarioni, M, Slachevsky, A, Suarez-Gonzalez, A, Tee, BL, Tsoy, E, Ulugut, H, Onyike, CU, Babulal, GM. Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research. ALZHEIMERS & DEMENTIA. 2024; DOI:10.1002/alz.14312. PMID:39535468. IF:11.100(Q1/1D).

Kishnani, PS, Byrne, BJ, Claeys, KG, Díaz-Manera, J, Dimachkie, MM, Kushlaf, H, Mozaffar, T, Roberts, M, Schoser, B, Hummel, N, Kopiec, A, Holdbrook, F, Shohet, S, Toscano, A. Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease. Journal Of Patient-Reported Outcomes. 2024; 8(1)DOI:10.1186/s41687-024-00805-w. PMID:39535661. IF:(Q/D).

Martinez, BB, Dragos, L, Tatanis, V, Somani, B, Martinez, PC, Angerri, O, Peteinaris, A, Tsaturyan, A, Kanashiro, A, Valverde, M, Serrano, MCG, Vivo, JL, Arteaga, SF, Liatsikos, E, Kallidonis, P. Pressure reduction and suction characteristics of the new digital single use flexible ureteroscope with suction: an in-vitro experimental study. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05334-1. PMID:39532737. IF:2.900(Q2/3D).

Rodríguez-Jorge, F, Fernández-Velasco, JI, Villarrubia, N, Gracia-Gil, J, Fernández, E, Meca-Lallana, V, Díaz-Pérez, C, Sainz de la Maza, S, Pacheco, EM, Quiroga, A, Ramió-Torrentà, L, Martínez-Yélamos, S, Bau, L, Monreal, E, López-Real, A, Rodero-Romero, A, Borrega, L, Díaz, S, Eguía, P, Espiño, M, Chico-García, JL, Barrero, FJ, Martínez-Ginés, ML, García-Domínguez, JM, De la Fuente, S, Moreno, I, Sainz-Amo, R, Mañé-Martínez, MA, Caminero, A, Castellanos, F, Gómez López, A, Labiano-Fontcuberta, A, Ayuso, L, Abreu, R, Hernández, MA, Meca-Lallana, J, Martín-Aguilar, L, Muriel García, A, Masjuan, J, Costa-Frossard, L, Villar, LM. Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis. Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1480676. PMID:39606235. IF:5.900(Q1/2D).